
Researchers assessed prostate cancer podcasts for quality, understandability, misinformation, and commercial bias. Results revealed lacking quality based on DISCERN criteria, unclear understandability, and not actionable via PEMAT. For patients and families seeking reliable info, podcasts may not be ideal sources.
Like
Save
Share